Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.34
Price to sales ratio
0.65

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3586
BDSX
Biodesix, Inc. - Common Stock
21.42 USD0.00%-1.70%+34.97%+71.22%216.53 M USD
3816
IMDX
Insight Molecular Diagnostics Inc. - Common Stock
4.59 USD-9.65%-18.76%-20.45%+61.05%148.21 M USD
3923
BNR
Burning Rock Biotech Limited - American Depositary Shares
10.64 USD-5.84%+3.00%+24.59%-64.44%115.13 M USD
3985
XGN
Exagen Inc. - Common Stock
4.14 USD-6.97%-5.69%-12.84%-41.69%100.02 M USD

Frequently asked questions about Neuronetics, Inc. - Common Stock

What is the Neuronetics, Inc. - Common Stock stock price today?

The current price of Neuronetics, Inc. - Common Stock (STIM) is 1.79. Over the past 24 hours, the stock has changed by +1.70%. Follow the STIM chart for real-time price dynamics.

What is the stock ticker of Neuronetics, Inc. - Common Stock?

Neuronetics, Inc. - Common Stock trades under the ticker STIM. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Neuronetics, Inc. - Common Stock stock going up?

STIM has changed by +15.48% over the last week, +30.66% over the last month, and -53.75% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Neuronetics, Inc. - Common Stock net income for the last quarter?

Neuronetics, Inc. - Common Stock reported net income of -10.79 M for the last quarter. The previous quarter showed -7.16 M, which means net income changed by -50.74%.

How many employees does Neuronetics, Inc. - Common Stock have?

As of the latest available data, Neuronetics, Inc. - Common Stock has 658 employees. Workforce size can provide additional context about the company's scale and operations.

What is Neuronetics, Inc. - Common Stock EBITDA?

Neuronetics, Inc. - Common Stock EBITDA is -10.55 M, and its EBITDA margin is -32.81%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Neuronetics, Inc. - Common Stock stock?

You can buy Neuronetics, Inc. - Common Stock (STIM) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Neuronetics, Inc. - Common Stock stock?

Investing in Neuronetics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the STIM chart and related analysis on metatrader.com as part of your research.

Neuronetics, Inc. - Common Stock

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. Neuronetics became the "first and only Food and Drug Administration approval for the clinical treatment of a specific form of medication-refractory depression using a TMS Therapy device." They manufacture a transcranial magnetic stimulation device, NeuroStar. The NeuroStar TMS therapy is delivered via a precisely positioned magnetic coil against the patient's head.

News